RxDoctor Payments Data

Esmeralda Park, MD

Neurology · Arlington Heights, ILNPI 1881854677

Payments from drug & device makers

$973in general payments, 2019–2025

Across 41 payments — averaging $23.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$291
  • Sunovion Pharmaceuticals Inc.$156
  • SK Life Science, Inc.$151
  • Catalyst Pharmaceuticals, Inc.$79
  • Eisai Inc.$74
  • Supernus Pharmaceuticals, Inc.$51
  • plus $172 from 7 others

What the payments were for

  • Food & beverage$95798%
  • Education$172%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$973 in reported general payments places this provider in the 50th percentile of 790 neurology providers in Illinois.

See all neurology providers in Illinois

Medicare billing

Part B allowed, 2024
$17,348
Medicare patients
125
Services billed
276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SabrilVigabatrin13$464,699
BriviactBrivaracetam84$184,202
EpidiolexCannabidiol (Cbd)28$83,644
FycompaPerampanel14$60,166
Lamictal XrLamotrigine15$60,067
KeppraLevetiracetam13$49,310
LamictalLamotrigine16$29,515
NayzilamMidazolam28$20,341
Lacosamide62$12,480
Levetiracetam239$11,948
Clobazam42$11,564
Divalproex Sodium ErDivalproex Sodium108$8,542
Carbamazepine ErCarbamazepine71$8,476
Divalproex Sodium78$6,649
DilantinPhenytoin Sodium Extended19$4,744

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
UCB, Inc.Briviact, Nayzilam$291$204,543112 claims
Eisai Inc.Fycompa$74$60,16614 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 790 neurology providers in Illinois.

Other neurology in Arlington Heights

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →